Medical testing startup Theranos has agreed to publish data that it says will validate the accuracy of its blood tests after they were called into question by a Wall Street Journal article published last week.
Elizabeth Holmes, the billionaire CEO of the rapidly growing company, confirmed that Theranos would make the information public in a bid to quell attacks claiming the company wasn’t using its own technology in its tests. “Data is a powerful thing because it speaks for itself,” she said, speaking at a conference sponsored by the Cleveland Clinic on Monday night. Holmes did not say when or where her company would actually make the information public.
This article originally appeared on Recode.net.